Ebola Hides In The Eyes Of A Man Who Was Considered Cured : Shots - Health News Weeks after being diagnosed with Ebola, a doctor came down with a dangerous eye infection. Ebola was lurking there. Other Ebola victims face the risk of blindness through these delayed infections.
NPR logo

Ebola Hides In The Eyes Of A Man Who Was Considered Cured

  • Download
  • <iframe src="https://www.npr.org/player/embed/404736240/405260496" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
Ebola Hides In The Eyes Of A Man Who Was Considered Cured

Ebola Hides In The Eyes Of A Man Who Was Considered Cured

  • Download
  • <iframe src="https://www.npr.org/player/embed/404736240/405260496" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript


Dr. Ian Crozier was successfully cured from Ebola last year - or so he thought. He had fought for his life. Dr. Crozier became ill with the disease in Sierra Leone, where he'd been volunteering in an Ebola treatment unit - an ETU. After six weeks at Emory University Hospital in Atlanta last fall, his blood was declared Ebola free.

What he and his physicians did not know was that the virus was still lurking in his left eye. Yesterday, at a national ophthalmology conference, he and his doctors discussed his case, and their account was published in the New England Journal of Medicine. Dr. Crozier joins us now from Denver. Thanks for - thanks for joining us.

IAN CROZIER: Good afternoon, Robert. It's good to be with you.

SIEGEL: And tell us, when did you first realize after you'd been declared Ebola-free that there was something wrong with your eye?

CROZIER: I had very mild occasional burning and occasional light sensitivity in the eye, but really wasn't having very many symptoms. In fact, it was hearing that there were some early reports of survivors from Sierra Leone who were developing some eye symptoms that made me pay attention. And that's when I first met the team at Emory ophthalmology.

SIEGEL: How did they figure out that it was Ebola?

CROZIER: Well, initially when they first saw me, my examination was normal. I was having no symptoms, although I did have dark scars, I would say, on the back of my eye - on the retina. They were unusual, and it was a month later that I presented with eye symptoms and was diagnosed with an inflammatory process in the eye that we call uveitis.

SIEGEL: At the risk of making our listeners feel queasy right now, how does one go about the testing what's inside your eye?

CROZIER: Well, four days after the onset of my symptoms, my eye pain and redness was getting worse. So on a Sunday afternoon at the Emory Eye Clinic, the ophthalmologist, which is Steve Yeh, put a 30 gauge needle in through the white part of my eye and directed it towards the dark space right above the pupil. And he took a small amount of fluid from that eye.

I remember at the time turning to those in the room and saying surely this is not going to be Ebola. But just in case it is, remember what it feels like to be right in the middle of a paradigm shift. And a few hours later, the PCR came back positive.


CROZIER: And it came back positive at higher levels than it had been even in my blood.

SIEGEL: What did you think or fear at that moment when you had that diagnosis?

CROZIER: It was obviously odd to realize that this virus that I'd already sort of had an intimate dance with had been squatting in the eye ever since without paying rent for the past three months. It was a shock to realize it. And as the process evolved, it became very difficult to understand in what essentially was a new disease how best to care for the eye.

SIEGEL: What does one do at that point? I mean, you'd already gone through all of the hydration or whatever one does for having Ebola in your bloodstream. What's the treatment for Ebola in the eye?

CROZIER: We began to look at this as a standard uveitis. There are other infections that cause inflammation in the eye. And one of the cornerstones of those treatments is to give topical anti-inflammatory steroids. Despite that, the eye continued to evolve, and eventually we needed to make a decision about whether we could try and change the playing field given the fact that the eye was getting worse and I was going blind basically over the next weeks.

SIEGEL: Dr. Crozier, you're being admirably clinical about this right now with the benefit of it all being in the past. But what a relationship you had with this disease by that time - you had gone to Africa as a volunteer for the World Health Organization to treat people. You had contracted Ebola. You had been declared free of Ebola. You are now battling Ebola in the eye. Do you feel as though you have some personal relationship with this disease - some grudge match with this disease?

CROZIER: (Laughter) Yeah, I suppose - I suppose there's an element of that for sure. You know, I'll tell you, as the eye process evolved - of course, it's a shock to find it in the eye - but as - as it - the disease evolved, you know, some other things happened. My pressure went down, my eye was changing shape. And then I had a bizarre color change in the eye. And though, of course, you worry more about losing your sight, I found that actually quite a personal affront.

SIEGEL: Your blue eyes turned green at some point.

CROZIER: Yes, my left eye suddenly turned quite a bright green.

SIEGEL: This is rare, obviously, but is there any reason to believe that there aren't hundreds of people in West Africa who survived Ebola but who still have the virus in the eye?

CROZIER: Yes, I'm really glad you asked that question. You know, I suppose I struggle a bit with an unwarranted but still present survivor's guilt when I think about the access to care that I received. And in one sense, I'm extremely grateful to the WHO and the State Department for enabling that evacuation. I would have been dead in a week had that not happened. On the other sense, you know, I'm haunted by my patients. And so it's particularly important to me to make sure that the technical expertise and what we learned around my eye was able to very quickly and nimbly make its way back to African eyes.

SIEGEL: How does it feel as a doctor to moonlight as a famous case in this instance - be a famous patient for once?

CROZIER: You know, I've begun to talk about this space as a dual citizenship of sorts. And it's a very interesting space, Robert, I'm still learning about, but it is extremely gratifying if the care that I received can make a difference back on the ground in West Africa. I'd been there for years, and so it's really important to me that the northern sort of expertise that I've been offered and have benefited from is able to be quickly and in an agile way translated back on West African land.

SIEGEL: Dr. Crozier, thank you very much for talking with us.

CROZIER: You're very welcome. My pleasure.

SIEGEL: Dr. Ian Crozier spoke with us from Denver.


Copyright © 2015 NPR. All rights reserved. Visit our website terms of use and permissions pages at www.npr.org for further information.

NPR transcripts are created on a rush deadline by Verb8tm, Inc., an NPR contractor, and produced using a proprietary transcription process developed with NPR. This text may not be in its final form and may be updated or revised in the future. Accuracy and availability may vary. The authoritative record of NPR’s programming is the audio record.